Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis

Am J Respir Crit Care Med. 2019 Aug 1;200(3):274-275. doi: 10.1164/rccm.201812-2330ED.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Telomerase / genetics*
  • Telomere
  • Telomere Shortening

Substances

  • Telomerase